2023 New Investigator Research Grant

Eligibility

Eligibility Criteria

• New investigators are considered to be within seven years of their first independent faculty-level position when the grant would be awarded. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years and are not included in the seven-year guideline.
• Researchers must be in an independent faculty-level position at the time the application is submitted.
• Adjustments for career interruptions can be made. These could include but are not limited to family leave, military service, major illness, or injury. It is the responsibility of the applicant to point out and document such interruptions.
• Applicants are not required to be US citizens. Research projects from outside the US are eligible.
• Applicants with a KO8, R00, or R99 grant are eligible. The total grant amount will not be applied toward the $175K per year threshold on total direct costs.
• DOE, DOD, NSF, R21, or other grants with less than $175K per year in total direct costs are permitted.
• Only one LOI may be submitted from the same applicant (Principal Investigator).

Not Eligible

• Applicants with any active single grant (or multiple grants added together) that total $175K or greater in total direct costs per year are not eligible (as noted above, KO8, R00, R99 grant awards are excluded from this total threshold).
• Fellows are not eligible to apply.
• Applicants with NIH RO1 funding, VA Merit Award, or equivalent.
• Renewal applications will not be accepted.
• Co-PI's are not permitted.

Summary

The Leukemia Research Foundation's New Investigator Research Grant Program supports early-career investigators of exceptional creativity who propose highly innovative research projects with the potential to impact broad, essential areas of leukemia research. For the program to support the best and brightest minds, applications are sought from investigators who reflect the full diversity of the research workforce and represent diverse backgrounds, institutions, and geographic locations. Grants of up to $150K are awarded over a two-year period to new investigators -- researchers within seven years of their first independent faculty-level position.

Funding Details

• The maximum funding request is $150k over a two year period.
• The Leukemia Research Foundation does not provide funds for capital equipment (i.e., equipment purchases above $7,500). Any request for an exception to this policy must detail the specific need of the capital equipment for the proposed research project.
• Salary support for the principal investigator is not provided.
• Using funds for research travel is permitted but should not exceed $3K. The funds are intended only to enhance the study.
• All other support for the project must be detailed, including all sources for the requested and related projects. Any funding overlap must be clearly indicated.
• Indirect cost recovery or institutional overhead costs are not provided.

Pre-application deadlines

RSO internal deadline

Pre-application program deadline

Application deadlines

RSO detailed review deadline

RSO final internal review deadline

Program application deadline

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

• Principal Investigator
• Department Head
• Faculty ADR/Dean
• Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.

Application Process

Letter of Intent

1. The Principal Applicant will first have to set up a personal account on Proposal Central (if not already in the PC database)
2. Complete a Letter of Intent according to the Leukemia Research Foundation's 2023 New Investigator Research Grant Guidelines
3. Complete a Pre-Award/Letter of Intent record in RMS (https://my.rms.ucalgary.ca/), attach your completed Letter of Intent, and submit for approvals from your department head and/or faculty Associate Dean (Research). NOTE: when submitting in RMS, please ensure that you allow time for academic approvals prior to the Research Services Office internal review deadline of 12:00pm MT, February 23, 2023.
4. Once these approvals are obtained, RMS will automatically forward the pre-award/Letter of Intent record to Research Services for institutional review and approval.
5. Upon receiving notification of institutional approval, submit your Letter of Intent, including any supplementary documentation, must be submitted via ProposalCentral by 12:00pm CT, February 28, 2023.

Full application 

After the LOI review, the researchers selected to submit a full application will receive an email with instructions and a link to the full application. Please inform Research Services (rsogrants@ucalgary.ca) if you are invited to submit a full application.